MyoKardia (MYOK) Commences Patient Dosing in Phase 1b Clinical Study of MYK-491

February 14, 2018 8:35 AM

MyoKardia, Inc. (NASDAQ: MYOK) today announced that dosing has commenced in a Phase 1b single-ascending dose patient study of its ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found